Related Experiment Videos
Impaired vascular responses to nitroglycerin in subjects with coronary atherosclerosis
O T Raitakari1, J P Seale, D S Celermajer
1Department of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia.
Insights
Smooth muscle dysfunction is evident in coronary artery disease patients. Higher nitroglycerin doses were needed to dilate blood vessels in these patients compared to healthy controls, indicating impaired vascular response.
Area of Science:
- Cardiovascular Medicine
- Vascular Biology
- Smooth Muscle Physiology
Background:
- Atherosclerosis is a chronic inflammatory disease characterized by plaque buildup in arteries.
- Smooth muscle cell dysfunction plays a critical role in the pathogenesis of atherosclerosis and vascular complications.
- Assessing endothelial and smooth muscle function is crucial for understanding cardiovascular disease progression.
Purpose of the Study:
- To investigate and quantify smooth muscle function in individuals with coronary artery disease (CAD).
- To compare the vasodilator response to nitroglycerin between patients with CAD and healthy controls.
- To determine if impaired smooth muscle function is a characteristic feature of atherosclerosis.
Main Methods:
- Dose-response curves were generated by measuring brachial artery diameter changes.
- Incremental sublingual doses of nitroglycerin were administered to participants.
- The study included patients diagnosed with coronary artery disease and a control group of healthy individuals.
Main Results:
- The dose of nitroglycerin required to achieve a 50% maximal dilator response was significantly higher in CAD patients.
- CAD patients exhibited a blunted vasodilator response compared to controls (p < 0.002).
- These findings indicate a functional impairment of vascular smooth muscle in atherosclerosis.
Conclusions:
- Smooth muscle dysfunction is significantly associated with coronary artery disease.
- Impaired nitroglycerin-induced vasodilation suggests compromised smooth muscle responsiveness in atherosclerosis.
- These results highlight the importance of smooth muscle function in the context of cardiovascular disease.
Abstract:
To study smooth muscle function in atherosclerosis, we calculated dose-response curves in patients with coronary artery disease and in controls by measuring changes in brachial artery diameter after incremental sublingual doses of nitroglycerin. The doses required to produce a 50% maximal dilator response were significantly higher in patients with coronary artery disease than in controls (p <0.002), suggesting smooth muscle dysfunction in atherosclerosis.